2-氟-4-甲氧基-1-异丙基苯, 98%

2-Fluoro-1-isopropyl-4-methoxybenzene

[2-（4-溴-3,5-二甲基-1H-吡唑-1-基）乙基]胺

[2-(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)ethyl]amine

3-溴-5-苯基-1,2,4-恶二唑, 98%

3-Bromo-5-phenyl-1,2,4-oxadiazole

聚苊

average M_w 5,000-10,000, powder

平均Mw5000-10000,粉末

GHK-Cu醋酸盐, 99%

GHK-Cu acetate

Cy7.5 马来酰亚胺

Cy7.5 maleimide

ERK抑制剂II，阴性对照

ERK Inhibitor II, Negative Control

[S(R)]-N-[(R)-[3,5-二叔丁基-4-甲氧基苯基][2-(二叔丁基膦)苯基]甲基]-2-叔丁基亚磺酰胺

[S(R)]-N-[(R)-[3,5-Bis(1,1-dimethylethyl)-4 methoxyphenyl][2-(di-tert-butylphosphino)phenyl]methyl]-2-methyl-2-propanesulfinamide

≥98%

5,7-二氯-2-环丙基-2H-吡唑并[4,3-d]嘧啶

5,7-dichloro-2-cyclopropyl-2H-pyrazolo[4,3-d]pyrimidine

98%

4,4,5,5-tetramethyl-2-_{4-[(3-methylphenyl)methoxy]phenyl}-1,3,2-dioxaborolane, 98%

4,4,5,5-tetramethyl-2-_{4-[(3-methylphenyl)methoxy]phenyl}-1,3,2-dioxaborolane

布洛芬杂质G

Pharmaceutical Secondary Standard; Certified Reference Material

9,9'，9“ - （5-（4,6-二苯基-1,3,5-三嗪-2-基）苯-1,2,3-三基）三（9H-咔唑）

TCzTrz

Sublimed,>99.9%(HPLC...

(2-甲氧基-5-(N-甲基氨磺酰)苯基)硼酸, 99%

(2-Methoxy-5-(N-methylsulfamoyl)phenyl)boronic acid

2,4-二氯苄基胩

2,4-Dichlorobenzylisocyanide

≥98%

4-(1H-imidazo[4,5-f][1,10]phenanthrolin-2-yl)benzoic acid, 99%

4-(1H-imidazo[4,5-f][1,10]phenanthrolin-2-yl)benzoic acid

7-苄基3-叔丁基3,7-二氮杂双环[4.2.0]辛烷-3,7-二羧酸酯

7‐benzyl 3‐tert‐butyl 3,7‐diazabicyclo[4.2.0]octane‐3,7‐dicarboxylate

98%

石英砂, AR,6-10目或2-3mm

Silica sand

ICA-27243

ICA-27243

≥99.9%

4-(4-甲基哌嗪-1-基)-7-(三氟甲基)吡咯并[1,2-a]喹喔啉, 99%

4-(4-Methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline

N'-异丙亚基-2-硝基苯磺酰

N-Isopropylidene-N'-2-nitrobenzenesulfonyl hydrazine

99%